Compare JACK & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JACK | NYXH |
|---|---|---|
| Founded | 1951 | 2009 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.8M | 152.8M |
| IPO Year | 1994 | 2021 |
| Metric | JACK | NYXH |
|---|---|---|
| Price | $11.46 | $2.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 3 |
| Target Price | ★ $22.40 | $9.33 |
| AVG Volume (30 Days) | ★ 964.4K | 53.7K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,465,314,000.00 | N/A |
| Revenue This Year | N/A | $214.32 |
| Revenue Next Year | $1.04 | $124.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.92 | $2.76 |
| 52 Week High | $27.74 | $8.64 |
| Indicator | JACK | NYXH |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 39.61 |
| Support Level | $8.92 | $2.76 |
| Resistance Level | $20.96 | $5.02 |
| Average True Range (ATR) | 0.82 | 0.18 |
| MACD | 0.45 | 0.03 |
| Stochastic Oscillator | 73.45 | 20.45 |
Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America. Its core business includes the Jack in the Box hamburger chain, known for a broad menu that features hamburgers, tacos, sandwiches, salads, and breakfast items. The company also operates the Del Taco brand, which offers a variety of both Mexican and American favorites such as burritos and fries. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.